PPARGC1A and metabolic dysfunction-associated steatotic liver disease: The PGC1α activity and mitochondrial homeostasis have been impaired in steatotic liver in a NAFLD mouse model [17], whereas PGC-1α overexpression results in increased hepatic FAO with reduced triacylglycerol accumulation and secretion in the rat liver [16].